COMANAGEMENT OF THE PATIENT ON SUBCUTANEOUS TERBUTALINE PUMP THERAPY

Authors

  • Ruth J. Stanton CNM, MS

    Corresponding authorSearch for more papers by this author
    • Ruth J. Stanton, CNM, ms, received her B.S.N, from Baylor University and her M.S. and Certificate in Nurse-Midwifery from the University of Utah. She is currently a perinatal consultant for Piedmont Obstetrical Home Care, Greenville, South Carolina, a company providing high-risk outpatient perinatal nursing services. This company is a subsidiary of Medical Resource Management, which has a two and one half year pool of experience with over 1,000 preterm labor patients.


108 Village Court, Greer. SC 29651.

ABSTRACT

The subcutaneous terbutaline pump is a new modality available for pharmacologic treatment of preterm labor. Because nurse-midwives may be involved in the care of women on this therapy, an overview of terbutaline pharmacology, pump development, and advantages versus disadvantages of this therapy is provided. Initiation of therapy in the appropriate patient is described. Outpatient therapy is the goal for these women, and the nurse-midwife may appropriately comanage this aspect of care. Guidelines are presented for physical and psychosocial care.

Ancillary